Business Context and Reporting Period
Company: Byline Bancorp, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 27, 2023
Reporting Period: Second Quarter ended June 30, 2023
This filing serves as a notification that the Company issued a press release and a slide presentation regarding its financial results for the second quarter of 2023. The detailed financial data is contained within the attached exhibits (Exhibit 99.1 and 99.2) and is incorporated by reference.
Key Financial Metrics
The provided text is a cover document for the Form 8-K and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are located in the attached press release (Exhibit 99.1) and slide presentation (Exhibit 99.2), which are not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the announcement of the second quarter 2023 results.
Guidance, Outlook, and Risks
Forward-Looking Statements: The filing includes a standard disclaimer regarding forward-looking statements. These statements involve estimates, forecasts, and projections concerning future performance and are subject to risks and uncertainties.
- Risk Factors: The document directs investors to the "Risk Factors" section of the Annual Report on Form 10-K for the year ended December 31, 2022, for a detailed list of risks that could cause actual results to differ materially from projections.
- Limitations: The Company explicitly states it undertakes no obligation to update forward-looking statements unless required by federal securities laws.
Investor Verification Checklist
- Review Exhibit 99.1: Verify the specific revenue, net income, and earnings per share figures in the attached press release.
- Review Exhibit 99.2: Examine the slide presentation for management commentary on liquidity, loan portfolio performance, and deposit trends.
- Check Form 10-K: Consult the 2022 Annual Report for the comprehensive list of risk factors referenced in this filing.
- Conference Call: Note that a conference call was scheduled for July 28, 2023, to discuss these results; verify if a transcript is available for further detail.